ELECTROPHYSIOLOGICAL EFFECTS OF NEURAL REMODELING OF THE VENTRICLES
心室神经重塑的电生理效应
基本信息
- 批准号:8603270
- 负责人:
- 金额:$ 37.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-15 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdrenergic AgentsAdrenergic FibersAnimal ModelAnimalsAreaArrhythmiaAttenuatedAutonomic nervous systemBilateralBiochemicalBiopsyCardiacCardiomyopathiesCardiovascular systemCathetersCessation of lifeChestCicatrixClinicalCoronaryDiseaseEfferent NeuronsElectrophysiology (science)EndocardiumEpicardiumEpidural AnesthesiaExcisionFiberFunctional disorderGangliaGoalsHealthHeartHeart TransplantationHistologyHumanImplantable DefibrillatorsInfusion proceduresKnowledgeLeftMapsMeasurementMorbidity - disease rateMyocardialNerveNitroprussideNorepinephrineOperative Surgical ProceduresOutputPathway interactionsPatientsPlayPreventionProceduresPropertyProtocols documentationPulmonary artery structureRecoveryRegulationResearchRiskRoleStructure of stellate ganglionSympathectomySympathetic GangliaTestingTherapeuticTherapeutic InterventionThoracic spinal cord structureUnited StatesVentricularVentricular ArrhythmiaVentricular FibrillationVentricular RemodelingVentricular TachycardiaVentricular septumWorkadrenergicbaseclinical practicecostcost effectivedensityimprovedin vivomortalitynerve supplynovelpericardial sacpreventpublic health relevanceregional differencerelating to nervous systemresponsesudden cardiac deaththerapy development
项目摘要
DESCRIPTION (provided by applicant): Sudden cardiac death (SCD) due to ventricular arrhythmias is the leading cause of mortality in the United States, resulting in 250,000 deaths/year. The autonomic nervous system plays a major role in the pathophysiology of arrhythmias leading to SCD and neuraxial modulation provides an important venue for therapeutic intervention. The major goal of our research is to investigate the role of cardiac sympathetic innervations in the genesis of arrhythmias, and that of neuraxial modulation in prevention of these arrhythmias in humans. The mechanisms underlying sympathetic control of myocardial excitability in normal and diseased human hearts, and specifically, regional differences (apex versus base, epicardium versus endocardium, right versus left stellate ganglion innervation) remain unknown and need to be studied. Further, myocardial scars seen in ischemic and non-ischemic cardiomyopathy show nerve sprouting at the border zone of scars due to neural remodeling, which has been implicated in the pathophysiology of ventricular arrhythmias. The functional effects of nerve stimulation in this setting and how neuraxial blockade works in humans in these diseases are still unknown and this knowledge can help guide therapy. In this proposal, electrophysiological effects of direct regional cardiac nerve stimulation and neuraxial modulation of the thoracic sympathetic ganglia will be investigated. Areas of the heart regulated by the right and left stellate ganglia will be delineated in patients undergoing interventional electrophysiology procedures and cardiac transplantation. Understanding neuraxial modulation has the potential to further develop therapies that target these pathways in the very near term. Therapies such as right, left, or bilateral cerviocothoracic sympathectomy which has been 're-introduced' into clinical practice (by our group and others) already show a lot of promise and could emerge as novel/elegant therapies that are also cost-effective for the prevention of SCD. Therefore, neuraxial modulation is an approach that has the potential to have a global impact given the prohibitive high cost and morbidity associated with implantable defibrillators which prevent their expanded use.
描述(申请人提供):由室性心律失常引起的心脏性猝死(SCD)是美国主要的死亡原因,每年造成250,000人死亡。自主神经系统在导致SCD的心律失常的病理生理学中起着重要作用,神经轴调节为治疗干预提供了重要场所。我们研究的主要目的是探讨心脏交感神经支配在心律失常发生中的作用,以及神经轴调节在人类预防这些心律失常中的作用。交感神经控制正常人和疾病心脏心肌兴奋性的机制,特别是区域差异(心尖与心底、心外膜与心内膜、右与左星状神经节支配)仍不清楚,需要进行研究。此外,在缺血性和非缺血性心肌病中所见的心肌瘢痕由于神经重构而在疤痕的边缘区域出现神经萌发,这与室性心律失常的病理生理学有关。在这种情况下,神经刺激的功能效应以及神经轴阻滞在人类中如何在这些疾病中发挥作用仍是未知的,这一知识可以帮助指导治疗。在这项建议中,将研究直接局部心脏神经刺激和胸交感神经节的神经轴调节的电生理效应。在接受介入性电生理程序和心脏移植的患者中,将描绘由左右星状神经节调节的心脏区域。了解神经轴调节有可能在短期内进一步开发针对这些通路的治疗方法。治疗方法,如右、左或双侧颈胸交感神经切断术,已经(由我们团队和其他人)重新引入临床实践,已经显示出很大的前景,并可能成为预防SCD的新的/优雅的疗法,也是具有成本效益的。因此,神经轴调制是一种有可能产生全球影响的方法,因为与植入式除颤器相关的高昂成本和发病率阻碍了它们的推广使用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KALYANAM SHIVKUMAR其他文献
KALYANAM SHIVKUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KALYANAM SHIVKUMAR', 18)}}的其他基金
Cardiac Neuromodulation: Mechanisms and Therapeutics
心脏神经调节:机制和治疗
- 批准号:
10627573 - 财政年份:2023
- 资助金额:
$ 37.98万 - 项目类别:
Neural Control of Myocardial Excitability at the Nerve Myocyte Interface
神经肌细胞界面心肌兴奋性的神经控制
- 批准号:
10627577 - 财政年份:2023
- 资助金额:
$ 37.98万 - 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
- 批准号:
10428718 - 财政年份:2019
- 资助金额:
$ 37.98万 - 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
- 批准号:
9808011 - 财政年份:2019
- 资助金额:
$ 37.98万 - 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
- 批准号:
10190645 - 财政年份:2019
- 资助金额:
$ 37.98万 - 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
- 批准号:
7078849 - 财政年份:2006
- 资助金额:
$ 37.98万 - 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
- 批准号:
7417817 - 财政年份:2006
- 资助金额:
$ 37.98万 - 项目类别:
ELECTROPHYSIOLOGICAL EFFECTS OF NEURAL REMODELING OF THE VENTRICLES
心室神经重塑的电生理效应
- 批准号:
8458497 - 财政年份:2006
- 资助金额:
$ 37.98万 - 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
- 批准号:
7616206 - 财政年份:2006
- 资助金额:
$ 37.98万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 37.98万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 37.98万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 37.98万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 37.98万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 37.98万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 37.98万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 37.98万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 37.98万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 37.98万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 37.98万 - 项目类别:














{{item.name}}会员




